Resources Contact Us Home
Assay for methylation in the GST-Pi gene

Image Number 10 for United States Patent #8088577.

A diagnostic or prognostic assay is disclosed for a disease of condition characterized by abnormal methylation of cytosine at side or sites within the glutathione-S-transferase (GST) Pi gene and/or its regulatory flanking sequences (e.g., prostate cancer and liver cancer). The assay comprises: (i) isolating DNA from said subject, and (ii) determining (e.g., by selective PCR amplification) the presence of abnormal methylation of cytosine at a site or sites within the GST-Pi gene and/or its regulatory flanking sequences.

  Recently Added Patents
Human renal disease marker substance
Automatic misalignment balancing scheme for multi-patterning technology
Resistor and manufacturing method thereof
Methods and apparatus for deactivating internal constraint curves when inflating an N-sided patch
1,3-diiodohydantoin compound and production method thereof
Method and apparatus for policy-based network access control with arbitrary network access control frameworks
Methods for processing 2Nx2N block with N being positive integer greater than four under intra-prediction mode and related processing circuits thereof
  Randomly Featured Patents
Methane conversion process
Power steering system
Locking device
Miniature rose variety `POULhilda`
Roller assembly of an undercarriage assembly having an integrated retainer and thrust bushing and method for making the same
Heat-seal splicing assembly and method
Devices as services in a decentralized operating system
Method and apparatus for candidate detection using Hessian peak characteristics
Visco-elastic delayed actuator and system
Device that provides the functionality of dual-ported memory using single-ported memory for multiple clock domains